ZTS Insider Trading

Insider Ownership Percentage: 0.16%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $312,254.08

Zoetis Insider Trading History Chart

This chart shows the insider buying and selling history at Zoetis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$4M-$2M$0$2M$4MTotal Insider BuyingTotal Insider Selling

Zoetis Share Price & Price History

Current Price: $153.78
Price Change: Price Increase of +0.312 (0.20%)
As of 04/28/2025 04:59 PM ET

This chart shows the closing price history over time for ZTS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$153.78Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for Zoetis (NYSE:ZTS)

92.80% of Zoetis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZTS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.09Bbought$301MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$50B$0$50BTotal InflowsTotal Outflows
Zoetis logo
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Read More on Zoetis

Today's Range

Now: $153.78
Low: $152.45
High: $154.78

50 Day Range

MA: $158.84
Low: $144.09
High: $171.70

52 Week Range

Now: $153.78
Low: $139.70
High: $200.33

Volume

1,873,396 shs

Average Volume

2,488,890 shs

Market Capitalization

$68.61 billion

P/E Ratio

28.11

Dividend Yield

1.30%

Beta

0.92

Who are the company insiders with the largest holdings of Zoetis?

Zoetis' top insider shareholders include:
  1. Kristin C Peck (CEO)
  2. Heidi C Chen (EVP)
  3. Roxanne Lagano (EVP)
  4. Willie M Reed (Director)
  5. Robert J Polzer (EVP)
Learn More about top insider investors at Zoetis.

Who are the major institutional investors of Zoetis?

Zoetis' top institutional investors include:
  1. Principal Financial Group Inc. — 0.55%
  2. Sarasin & Partners LLP — 0.46%
  3. GAMMA Investing LLC — 0.39%
  4. Vontobel Holding Ltd. — 0.38%
  5. Sarasin & Partners LLP — 0.35%
  6. Vaughan Nelson Investment Management L.P. — 0.27%
Learn More about top institutional investors of Zoetis stock.

Which institutional investors are selling Zoetis stock?

In the last quarter, ZTS stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Robeco Institutional Asset Management B.V.
  3. Sequoia Financial Advisors LLC
  4. Wealth Enhancement Advisory Services LLC
  5. Teacher Retirement System of Texas
  6. Fishman Jay A Ltd. MI
  7. Sumitomo Mitsui Trust Group Inc.
  8. Congress Asset Management Co.
During the previous year, company insiders that have sold Zoetis company stock include:
  1. Kristin C Peck (CEO)
  2. Heidi C Chen (EVP)
Learn More investors selling Zoetis stock.

Which institutional investors are buying Zoetis stock?

Within the last quarter, ZTS stock was purchased by institutional investors including:
  1. Sarasin & Partners LLP
  2. GAMMA Investing LLC
  3. Sarasin & Partners LLP
  4. Tandem Investment Advisors Inc.
  5. Artemis Investment Management LLP
  6. Confluence Investment Management LLC
  7. Vontobel Holding Ltd.
  8. Vantage Investment Partners LLC